{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:20:26Z","timestamp":1792102826303,"version":"4.4.0"},"reference-count":238,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T00:00:00Z","timestamp":1200873600000},"content-version":"vor","delay-in-days":9273,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Autonomic Pharmacology"],"published-print":{"date-parts":[[1982,9]]},"DOI":"10.1111\/j.1474-8673.1982.tb00489.x","type":"journal-article","created":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T08:45:47Z","timestamp":1200905147000},"page":"189-215","source":"Crossref","is-referenced-by-count":152,"title":["CARDIOVASCULAR DOPAMINE RECEPTORS: PHYSIOLOGICAL, PHARMACOLOGICAL AND THERAPEUTIC IMPLICATIONS"],"prefix":"10.1111","volume":"2","author":[{"given":"M. F.","family":"LOKHANDWALA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"BARRETT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,1,21]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.22.617"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1980.tb13087.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107743"},{"key":"e_1_2_1_5_1","first-page":"479P","article-title":"The action of dopamine on constrictor responses in the perfused rat mesenteric artery","volume":"66","author":"ANWAR N.","year":"1979","journal-title":"Br. J. Pharmac."},{"key":"e_1_2_1_6_1","first-page":"103","article-title":"Control of renin release in experimental hypertension","volume":"24","author":"AYERS C. R.","year":"1969","journal-title":"Circ. Res."},{"key":"e_1_2_1_7_1","first-page":"167","article-title":"Urinary dopamine in man and rat: effects of inorganic salts on dopamine excretion","volume":"55","author":"BALL S. G.","year":"1978","journal-title":"Clin. Sci. Mol. Med."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(71)90214-7"},{"key":"e_1_2_1_9_1","first-page":"660","article-title":"Presynaptic dopamine receptor stimulation in the cardiovascular actions of lergotrile","volume":"217","author":"BARRETT R. J.","year":"1981","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_10_1","article-title":"The role of alpha\u2010adrenergic and dopamine receptor activation in the cardiovascular effects of pergolide","volume":"40","author":"BARRETT R. J.","year":"1981","journal-title":"Fed. Proc."},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(82)90541-6"},{"key":"e_1_2_1_12_1","first-page":"39","article-title":"Presynaptic dopamine receptor stimulation and the antihypertensive action of pergolide in experimental neurogenic hypertension","volume":"25","author":"BARRETT R. J.","year":"1982","journal-title":"Proc. West. Pharmac. Soc."},{"key":"e_1_2_1_13_1","article-title":"Central dopaminergic mechanisms in the cardiovascular actions of intracisternally\u2010administered pergolide","volume":"41","author":"BARRETT R. J.","year":"1982","journal-title":"Fed. Proc."},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1980.tb14565.x"},{"key":"e_1_2_1_15_1","first-page":"17","article-title":"Effects of renal dopamine receptor and \u03b2\u2010adrenoceptor blockade on rises in blood angiotensin after haemorrhage, renal ischaemia and frusemide diuresis in the dog","volume":"54","author":"BELL C.","year":"1978","journal-title":"Clin. Sci. Mol. Med."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1979.tb08685.x"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1978.tb17297.x"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(74)90491-8"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(80)90002-5"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1978.tb07768.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1978.tb07801.x"},{"key":"e_1_2_1_22_1","first-page":"340P","article-title":"Vascular effects of bromocriptine in the hindlimb of the dog","volume":"62","author":"BOGAERT M. G.","year":"1978","journal-title":"Br. J. Pharmac."},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1977.tb07491.x"},{"key":"e_1_2_1_24_1","first-page":"657","article-title":"On the function of central catecholamine neurons \u2013 their role in cardiovascular and arousal mechanisms","volume":"4","author":"BOLME P.","year":"1972","journal-title":"Res. Commun. Chem. Pathol. Pharmac."},{"key":"e_1_2_1_25_1","first-page":"105","article-title":"Regulation of aldosterone secretion: current concepts and new aspects","volume":"8","author":"BRAVO E. L.","year":"1978","journal-title":"Adv. Nephrol."},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00507222"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90485-5"},{"key":"e_1_2_1_28_1","first-page":"57","volume-title":"Recent Advances in the Pharmacology of Adrenoceptors","author":"BROWN D. A.","year":"1978"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1958.tb00240.x"},{"key":"e_1_2_1_30_1","first-page":"327","article-title":"Tri\u2010pelennamine and dopamine\u2010induced neurogenic vasodilatation","volume":"220","author":"BUYLAERT W.","year":"1976","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_31_1","first-page":"738","article-title":"Vasodilatation produced by apomorphine in the hindleg of the dog","volume":"201","author":"BUYLAERT W. A.","year":"1977","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.49.6.1217"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00201a002"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109356"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109822"},{"key":"e_1_2_1_36_1","first-page":"271P","article-title":"Studies in the mechanism of the bradycardia produced by pergolide, a dopamine agonist, in the anesthetized rat","volume":"74","author":"CAVERO I.","year":"1981","journal-title":"Br. J. Pharmac."},{"key":"e_1_2_1_37_1","first-page":"515","article-title":"Blood pressure lowering effect of N, N\u2010di\u2010n\u2010propyldopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone","volume":"218","author":"CAVERO I.","year":"1981","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_38_1","first-page":"510","article-title":"Heart rate lowering effects of N, N\u2010di\u2010n\u2010propyl\u2010dopamine in rats: evidence for stimulation of central dopamine receptors leading to inhibition of sympathetic tone and enhancement of parasympathetic outflow","volume":"219","author":"CAVERO I.","year":"1981","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(82)90078-9"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1980.sp013093"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90268-1"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1980.tb10965.x"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-140-36394"},{"key":"e_1_2_1_44_1","first-page":"439","article-title":"Cardiovascular effects of ergot alkaloids","volume":"10","author":"CLARK B. J.","year":"1979","journal-title":"J. Pharmac. (Paris)"},{"key":"e_1_2_1_45_1","first-page":"160","article-title":"Peripheral dopamine receptors","volume":"46","author":"CLARK B. J.","year":"1980","journal-title":"Suppl. 1, Circ. Res."},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-66775-6_5"},{"key":"e_1_2_1_47_1","first-page":"160","article-title":"Peripheral dopamine receptors","volume":"46","author":"CLARK B. J.","year":"1980","journal-title":"Suppl. 1, Circ. Res."},{"key":"e_1_2_1_48_1","first-page":"230","article-title":"Inhibition of prolactin secretion by lergotrile mesylate: Mechanism of action","volume":"79","author":"CLEMENS J. A.","year":"1975","journal-title":"Acta Endocrinol."},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1978.sp012476"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1977.tb09742.x"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/259584a0"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0430481"},{"key":"e_1_2_1_53_1","first-page":"111","volume-title":"Presynaptic Receptors","author":"DALEMANS P.","year":"1979"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1976.tb08617.x"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(73)90126-X"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.451614"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1976.tb02802.x"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1975.tb09440.x"},{"key":"e_1_2_1_59_1","first-page":"144","article-title":"Dopamine and alpha\u2010adrenoceptor agonists inhibit neurotransmission in the cat spleen through different presynaptic receptors","volume":"212","author":"DUBOCOVICH M. L.","year":"1980","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_60_1","first-page":"259","article-title":"Cardiovascular effects of central micro\u2010injection of apomorphine in cats","volume":"215","author":"DUTTA S. N.","year":"1975","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_61_1","article-title":"Intrarenal dopaminergic receptors in control of renin release in the conscious dog","volume":"37","author":"DZAU V. J.","year":"1978","journal-title":"Fed. Proc."},{"key":"e_1_2_1_62_1","first-page":"64","article-title":"A proposed mechanism for the depressor effect of dopamine in the anesthetized dog","volume":"145","author":"EBLE J. N.","year":"1964","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1961.sp006738"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)92132-7"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.62.4.669"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00498689"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00501305"},{"key":"e_1_2_1_68_1","first-page":"F123","article-title":"Effects of saline and albumin on plasma and urinary catecholamines in dogs","volume":"232","author":"FACHEUX B.","year":"1977","journal-title":"Am. J. Physiol."},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198005000-00003"},{"key":"e_1_2_1_70_1","first-page":"271A","article-title":"Activation of presynaptic dopamine receptors in man: a new mechanism for after\u2010load reduction","volume":"29","author":"FENNEL W. H.","year":"1981","journal-title":"Clin. Res."},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(73)90125-8"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1979.tb00113.x"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00508279"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.26.481"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(79)96127-5"},{"key":"e_1_2_1_76_1","first-page":"363","article-title":"Effects of apomorphine and pimozide on temperature regulation during exercise in the rat","volume":"49","author":"GISOLFI C. V.","year":"1980","journal-title":"Am. J. Physiol."},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(68)90223-3"},{"key":"e_1_2_1_78_1","first-page":"1","article-title":"Cardiovascular and renal actions of dopamine: potential clinical applications","volume":"24","author":"GOLDBERG L. I.","year":"1972","journal-title":"Pharmac. Rev."},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(75)90239-7"},{"key":"e_1_2_1_80_1","first-page":"447","article-title":"Peripheral pre\u2010 and post\u2010synaptic dopamine receptors: Are they different from dopamine receptors in the central nervous system","volume":"3","author":"GOLDBERG L. I.","year":"1979","journal-title":"Comm. in Psychopharm."},{"key":"e_1_2_1_81_1","first-page":"2396","article-title":"Characteristics of the vascular dopamine receptor: Comparison with other receptors","volume":"37","author":"GOLDBERG L. I.","year":"1978","journal-title":"Fed. Proc."},{"key":"e_1_2_1_82_1","first-page":"212","article-title":"Effects of several monoamine oxidase inhibitors on the cardiovascular actions of naturally occurring amines in the dog","volume":"127","author":"GOLDBERG L. I.","year":"1959","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_83_1","first-page":"188","article-title":"An investigation of the structural requirements for dopamine\u2010like renal vasodilation: phenylethylamines and apomorphine","volume":"163","author":"GOLDBERG L. I.","year":"1968","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-017922-3.50094-0"},{"issue":"37","key":"e_1_2_1_85_1","first-page":"197","article-title":"Dopamine\u2010induced relaxation of isolated canine renal mesenteric, and femoral arteries contracted with prostaglandin F2\u03b1","volume":"36","author":"GOLDBERG L. I.","year":"1975","journal-title":"Suppl. I, Circ. Res."},{"key":"e_1_2_1_86_1","first-page":"149","volume-title":"Recent Advances in Clinical Pharmacology","author":"GOLDBERG L. I.","year":"1981"},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.18.040178.000421"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(71)90075-6"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.6.3725"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(79)90095-7"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1976.tb04877.x"},{"key":"e_1_2_1_92_1","first-page":"194","article-title":"Influence of apomorphine on sympathetic neural transmission in the nictitating membrane of the cat","volume":"226","author":"GYORGY L.","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(81)90705-0"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(81)90591-9"},{"key":"e_1_2_1_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198009000-00008"},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(81)90326-5"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198105000-00021"},{"key":"e_1_2_1_98_1","first-page":"135","volume-title":"New Antihypertensive Drugs","author":"HEISE A.","year":"1976"},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00500607"},{"key":"e_1_2_1_100_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1968.tb09776.x"},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-101-1-279"},{"key":"e_1_2_1_102_1","article-title":"Prejunctional dopaminergic activity of N, N\u2010dialkyl dopamine derivatives","volume":"39","author":"HIEBLE J. P.","year":"1980","journal-title":"Fed. Proc."},{"key":"e_1_2_1_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1979.tb08665.x"},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1978.tb17314.x"},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(77)90245-X"},{"key":"e_1_2_1_106_1","article-title":"Effects of (R) and (S) sulpiride on guinea pig blood pressure","volume":"39","author":"HORN P. T.","year":"1980","journal-title":"Fed. Proc."},{"key":"e_1_2_1_107_1","article-title":"Facilitation of sympathetic ganglionic transmission by (R)\u2010sulpiride","volume":"40","author":"HORN P. T.","year":"1981","journal-title":"Fed. Proc."},{"issue":"6","key":"e_1_2_1_108_1","first-page":"795","article-title":"Hypotensive effects of captopril, saralasin and bromocriptine in spontaneously hypertensive rats","volume":"59","author":"HUTCHINSON J. S.","year":"1980","journal-title":"Clin. Sci."},{"key":"e_1_2_1_109_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs061343s"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197918020-00005"},{"key":"e_1_2_1_111_1","first-page":"4","article-title":"Inhibition of the sympathetic nervous system for dopamine","volume":"216","author":"ILHAN M.","year":"1975","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_112_1","first-page":"247","article-title":"Inhibition of responses to stimulation of the cardioaccelerator nerves in the cat by N, N\u2010dimethyldopamine and apomorphine","volume":"212","author":"ILHAN M.","year":"1974","journal-title":"Arch. Int. Pharmacodyn."},{"key":"e_1_2_1_113_1","first-page":"70","article-title":"The ability of pimozide to prevent inhibition by dopamine analogs of cardioaccelerator nerves in cat hearts","volume":"222","author":"ILHAN M.","year":"1976","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_114_1","first-page":"193","article-title":"Effects of some dopamine analogs and haloperidol on response to stimulation of adrenergic nerves using cat atria in vitro","volume":"219","author":"ILHAN M.","year":"1976","journal-title":"Arch. Int. Pharmacodyn."},{"key":"e_1_2_1_115_1","first-page":"215","article-title":"Structure\u2010activity relationship studies of derivatives of aminotetralins and open chain analogs in relation to \u03b2 and \u03b1\u2010adrenoceptor agonist activities","volume":"223","author":"ILHAN M.","year":"1976","journal-title":"Arch. Int. Pharmacodyn."},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(75)90150-8"},{"key":"e_1_2_1_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198000021-00002"},{"key":"e_1_2_1_118_1","doi-asserted-by":"publisher","DOI":"10.1139\/y80-084"},{"key":"e_1_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)91556-7"},{"key":"e_1_2_1_120_1","first-page":"81","article-title":"The pharmacologic alteration of renin release","volume":"32","author":"KEETON T. K.","year":"1980","journal-title":"Pharmac. Rev."},{"key":"e_1_2_1_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90058-4"},{"key":"e_1_2_1_122_1","first-page":"239","article-title":"Pharmacology of 6,7\u2010dihydroxy\u20102\u2010dimethylaminotetralin (TL\u201099). 1. Cardiovascular activity in the dog and cat","volume":"206","author":"KITZEN J. M.","year":"1978","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_123_1","first-page":"519","article-title":"The effects of two analogs of dopamine on ganglionic transmission in the sympathetic nervous system","volume":"211","author":"KITZEN J. M.","year":"1979","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_124_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-51-1-152"},{"key":"e_1_2_1_125_1","first-page":"2198","article-title":"Studies with lergotrile mesylate in acromegaly","volume":"37","author":"KLEINBERG D. L.","year":"1978","journal-title":"Fed. Proc."},{"key":"e_1_2_1_126_1","first-page":"121","article-title":"Central cardiovascular \u03b1\u2010adrenoceptors","volume":"46","author":"KOBINGER W.","year":"1980","journal-title":"Circ. Res"},{"key":"e_1_2_1_127_1","first-page":"16","article-title":"N\u2010N\u2010di\u2010n\u2010propyldopamine: a qualitatively different dopamine vascular agonist","volume":"207","author":"KOHLI J. D.","year":"1978","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_128_1","first-page":"370","article-title":"Structure activity relationships of N\u2010substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors","volume":"213","author":"KOHLI J. D.","year":"1980","journal-title":"J. Pharmac, exp. Ther."},{"key":"e_1_2_1_129_1","first-page":"831","article-title":"The pharmacological evaluation of pergolide mesylate as a potential anti\u2010parkinson agent","volume":"19","author":"KOLLER W. C.","year":"1980","journal-title":"Neuro pharmacology"},{"key":"e_1_2_1_130_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.2.4.390"},{"key":"e_1_2_1_131_1","first-page":"273","article-title":"Effects of intracerebroventricular administration of dopamine and metoclopramide on blood pressure in rats","volume":"250","author":"KONDO K.","year":"1981","journal-title":"Arch. Int. Pharmacodyn"},{"key":"e_1_2_1_132_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs061235s"},{"key":"e_1_2_1_133_1","doi-asserted-by":"publisher","DOI":"10.1159\/000402132"},{"key":"e_1_2_1_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-023189-1.50047-8"},{"key":"e_1_2_1_135_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198011000-00014"},{"key":"e_1_2_1_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(81)90393-3"},{"key":"e_1_2_1_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(80)90969-5"},{"key":"e_1_2_1_138_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.38.6.560"},{"key":"e_1_2_1_139_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1979.tb13671.x"},{"key":"e_1_2_1_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-08-017922-3.50099-X"},{"key":"e_1_2_1_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(74)90187-7"},{"key":"e_1_2_1_142_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1977.tb07526.x"},{"key":"e_1_2_1_143_1","first-page":"337","article-title":"Presynaptic regulation of the release of catecholamines","volume":"32","author":"LANGER S. Z.","year":"1980","journal-title":"Pharmac. Rev."},{"key":"e_1_2_1_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(78)90026-2"},{"key":"e_1_2_1_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(77)90299-0"},{"key":"e_1_2_1_146_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.58.3.466"},{"key":"e_1_2_1_147_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.382359"},{"key":"e_1_2_1_148_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.91"},{"key":"e_1_2_1_149_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.67.2.667"},{"key":"e_1_2_1_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)90805-9"},{"key":"e_1_2_1_151_1","first-page":"367","article-title":"Dopamine\u2010induced inhibition of synaptic transmission in the inferior mesenteric ganglion of the dog","volume":"208","author":"LINS R. L.","year":"1974","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_152_1","first-page":"136","article-title":"Analysis of responses to dopamine in the mesenteric vascular bed of the cat","volume":"251","author":"LIPPTON H. L.","year":"1981","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_153_1","first-page":"662","article-title":"Consistent unmasking of dopamine\u2010induced dilation of the canine femoral vascular bed","volume":"215","author":"LISTINSKY J. J.","year":"1980","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90232-7"},{"key":"e_1_2_1_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90178-X"},{"key":"e_1_2_1_156_1","first-page":"101","article-title":"Evidence for a neurogenic mechanism in dopamine induced depressor response in the anesthetized dog","volume":"11","author":"LOKHANDWALA M. F.","year":"1979","journal-title":"Ind. J. Pharmac."},{"key":"e_1_2_1_157_1","first-page":"203","volume-title":"Central Nervous System Mechanisms in Hypertension","author":"LOKHANDWALA M. F.","year":"1981"},{"key":"e_1_2_1_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(76)90369-1"},{"key":"e_1_2_1_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(77)90394-0"},{"key":"e_1_2_1_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(77)90015-2"},{"key":"e_1_2_1_161_1","first-page":"362","article-title":"The effect of L\u2010dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors","volume":"204","author":"LOKHANDWALA M. F.","year":"1978","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_162_1","first-page":"120","article-title":"The role of sympathetic nervous system in the vascular actions of dopamine","volume":"210","author":"LOKHANDWALA M. F.","year":"1979","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_163_1","first-page":"620","article-title":"Cardiovascular actions of bromocriptine: evidence for a neurogenic mechanism","volume":"211","author":"LOKHANDWALA M. F.","year":"1979","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_164_1","first-page":"104","article-title":"Vascular and cardiac actions of N\u2010di\u2010alkyl dopamine analogs","volume":"245","author":"LONG J. P.","year":"1980","journal-title":"Arch. Int. Pharmacodyn."},{"key":"e_1_2_1_165_1","first-page":"336","article-title":"Inhibition of the sympathetic nervous system by 5,6\u2010dihydroxy\u20102\u2010dimethyl\u2010aminotetralin (M\u20107), apomorphine and dopamine","volume":"192","author":"LONG J. P.","year":"1975","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)91947-4"},{"key":"e_1_2_1_167_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00498427"},{"key":"e_1_2_1_168_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196612222752501"},{"key":"e_1_2_1_169_1","first-page":"H222","article-title":"Cerebral circulation: effect of stimulation and blockade of dopamine receptors","volume":"55","author":"McCULLOCH J.","year":"1977","journal-title":"Am. J. Physiol."},{"key":"e_1_2_1_170_1","first-page":"60","article-title":"Analysis of the cardiovascular effects of dopamine in the dog","volume":"140","author":"McDONALD R. H.","year":"1963","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_171_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI104996"},{"key":"e_1_2_1_172_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-39-2-391"},{"key":"e_1_2_1_173_1","first-page":"210","article-title":"Antihypertensive action of bromocriptine in neurogenic hypertensive dogs","volume":"252","author":"MONTASTRUC J. L.","year":"1981","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_174_1","first-page":"79","article-title":"Etude exp\u00e9rimentale de l'\u00e1ction antihypertensive de la bromocriptine chez le chien","volume":"10","author":"MONTASTRUC J. L.","year":"1979","journal-title":"J. Pharmac. (Paris)"},{"key":"e_1_2_1_175_1","first-page":"317","article-title":"Possible mechanisms involved in the depressor response to dopamine","volume":"212","author":"MORISHITA H.","year":"1974","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_176_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/1.suppl_2.5"},{"key":"e_1_2_1_177_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00506629"},{"key":"e_1_2_1_178_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-45-6-1313"},{"key":"e_1_2_1_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91935-3"},{"key":"e_1_2_1_180_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-48-1-37"},{"key":"e_1_2_1_181_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-51-1-64"},{"key":"e_1_2_1_182_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0560261"},{"key":"e_1_2_1_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)90917-X"},{"key":"e_1_2_1_184_1","first-page":"587","article-title":"Lack of effect of prolactin inhibition by alpha\u2010bromoergocriptine (CB154) on plasma aldosterone in anephric and non\u2010nephrectomized patients on regular hemodialysis","volume":"85","author":"OLGAARD K.","year":"1977","journal-title":"Acta Endocrinol."},{"key":"e_1_2_1_185_1","first-page":"105","volume-title":"New Antihypertensive Drugs","author":"OSBORNE M. W.","year":"1976"},{"key":"e_1_2_1_186_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-87-6-1306"},{"key":"e_1_2_1_187_1","first-page":"196","article-title":"Relaxation by dopaminergic agonists in cerebral and peripheral arteries (in vitro)","volume":"252","author":"OUDART N.","year":"1981","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_188_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(77)90056-8"},{"key":"e_1_2_1_189_1","first-page":"250","article-title":"Studies on the action and interaction of dopamine and prostaglandin A in the renal vasculature","volume":"221","author":"PENDLETON R. G.","year":"1976","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_190_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197612020-00001"},{"key":"e_1_2_1_191_1","first-page":"31","article-title":"Transmission blockade and stimulation of ganglionic adenylate cyclase by catecholamines","volume":"108","author":"QUENZER L.","year":"1979","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_192_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01963291"},{"key":"e_1_2_1_193_1","first-page":"94","volume-title":"Central Action of Drugs in Blood Pressure Regulation","author":"RAND M. J.","year":"1975"},{"key":"e_1_2_1_194_1","first-page":"283P","article-title":"Responses of the sympathetically\u2010innervated hepatic arterial vascular bed of the dog to intra\u2010arterial injections of dopamine","volume":"60","author":"RICHARDSON P. D. I.","year":"1977","journal-title":"Br. J. Pharmac."},{"key":"e_1_2_1_195_1","first-page":"86","article-title":"Systemic and renal hemodynamic effects of dopamine and prostaglandin A alonge and in combination","volume":"11","author":"ROBIE N.","year":"1974","journal-title":"Blood Vessels"},{"key":"e_1_2_1_196_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197917050-00002"},{"key":"e_1_2_1_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(74)90180-X"},{"key":"e_1_2_1_198_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1971.tb00600.x"},{"key":"e_1_2_1_199_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1974.tb00521.x"},{"key":"e_1_2_1_200_1","first-page":"13","article-title":"Inhibition of in vivo neural vasoconstriction by exogenous catecholamines","volume":"12","author":"SANDERS K. M.","year":"1975","journal-title":"Blood Vessels"},{"key":"e_1_2_1_201_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198009000-00009"},{"key":"e_1_2_1_202_1","first-page":"379P","article-title":"Dopamine receptor mediated inhibition by bromocriptine of accelerator nerve stimulation effects in the pithed cat","volume":"62","author":"SCHOLTYSIK G.","year":"1978","journal-title":"Br. J. Pharmac."},{"key":"e_1_2_1_203_1","article-title":"The effect of vasomotor agents on proximal tubular reabsorption in the dog","author":"SEELY D. F.","year":"1967","journal-title":"Ann. Mtg. Am. Neph."},{"key":"e_1_2_1_204_1","first-page":"229","article-title":"Brain dopamine receptors","volume":"32","author":"SEEMAN P.","year":"1980","journal-title":"Pharmac. Rev."},{"key":"e_1_2_1_205_1","first-page":"702","article-title":"The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs","volume":"192","author":"SETLER P. E.","year":"1975","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_206_1","first-page":"97","article-title":"Inhibition of canine adrenergic transmission by an analog of dopamine: GJH\u2010166","volume":"202","author":"SHARABI F. M.","year":"1977","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_207_1","first-page":"630","article-title":"Inhibiton of the sympathetic nervous system by a series of heterocyclic congeners of dopamine","volume":"199","author":"SHARABI F. M.","year":"1976","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_208_1","first-page":"457","article-title":"Centrally mediated hypotension and bradycardia induced by an aminotetralin derivative: TL\u201068","volume":"20","author":"SHARABI F. M.","year":"1978","journal-title":"Res. Comm. Chem. Pathol. Pharmac."},{"key":"e_1_2_1_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(68)90087-3"},{"key":"e_1_2_1_210_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00508805"},{"key":"e_1_2_1_211_1","doi-asserted-by":"publisher","DOI":"10.3109\/10641968109037164"},{"key":"e_1_2_1_212_1","doi-asserted-by":"publisher","DOI":"10.3109\/10641968109037165"},{"key":"e_1_2_1_213_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-164-40923"},{"key":"e_1_2_1_214_1","doi-asserted-by":"publisher","DOI":"10.1007\/BFb0050157"},{"key":"e_1_2_1_215_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.21.040181.000255"},{"key":"e_1_2_1_216_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.22933"},{"key":"e_1_2_1_217_1","first-page":"93","volume-title":"Presynaptic Receptors","author":"STEINSLAND O. S.","year":"1979"},{"key":"e_1_2_1_218_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92832-X"},{"key":"e_1_2_1_219_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(80)90203-9"},{"key":"e_1_2_1_220_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1979.tb13671.x"},{"key":"e_1_2_1_221_1","first-page":"518","article-title":"Reversal of acute renal failure with a combination of intravenous dopamine and diuretics","volume":"18","author":"TALLEY R. C.","year":"1970","journal-title":"Clin. Res."},{"key":"e_1_2_1_222_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198002003-00014"},{"key":"e_1_2_1_223_1","first-page":"511P","article-title":"Further evidence for dopaminoceptors in the vas deferens","volume":"59","author":"TAYO F. M.","year":"1977","journal-title":"Br. J. Pharmac."},{"key":"e_1_2_1_224_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)90546-2"},{"key":"e_1_2_1_225_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1974165part1782"},{"key":"e_1_2_1_226_1","first-page":"F542","article-title":"Renal handling of free and conjugated catechol\u2010amines following surgical stress in the dog","volume":"235","author":"UNGER T.","year":"1978","journal-title":"Am. J. Physiol."},{"key":"e_1_2_1_227_1","first-page":"1","article-title":"Antihypertensive drugs with a central action","volume":"1","author":"ZWIETEN P. A.","year":"1975","journal-title":"Prog. Pharmac."},{"key":"e_1_2_1_228_1","first-page":"221","article-title":"Dopamine receptor stimulating activity of 5\u2010hydroxy\u20106\u2010methyl\u20102\u2010aminotetralin derivatives","volume":"250","author":"VERIMER T.","year":"1981","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_229_1","first-page":"130","article-title":"Lack of correlation between inhibition of prolactin release and stimulation of dopaminergic renal vasodilatation","volume":"18","author":"VOLKMAN P. H.","year":"1976","journal-title":"Pharmacologist"},{"key":"e_1_2_1_230_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.8.3602"},{"key":"e_1_2_1_231_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00502578"},{"key":"e_1_2_1_232_1","first-page":"R47","article-title":"Renal hemodynamics, kidney function, and regional sympathetic activity during dopamine injection and infusion in the cat","volume":"307","author":"WASSERMAN K.","year":"1979","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmac."},{"key":"e_1_2_1_233_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00503977"},{"key":"e_1_2_1_234_1","first-page":"198","article-title":"Dopamine\u2010induced neurogenic vasodilatation: antagonism at the vascular level","volume":"204","author":"WILLEMS J. L.","year":"1973","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_235_1","first-page":"228","article-title":"Dopamine\u2010induced vasodilatation in the isolated perfused rat kidney","volume":"243","author":"WOODMAN O. L.","year":"1980","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_236_1","first-page":"203","article-title":"A comparison of the responses to some dopamine receptor agonists and antagonists in the isolated perfused rat kidney","volume":"248","author":"WOODMAN O. L.","year":"1980","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_2_1_237_1","first-page":"303","article-title":"Attenuation of dopamine renal and mesenteric vasodilatation by haloperidol: evidence for a specific dopamine receptor","volume":"168","author":"YEH B. K.","year":"1969","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_238_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90287-X"},{"key":"e_1_2_1_239_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90146-8"}],"container-title":["Journal of Autonomic Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1474-8673.1982.tb00489.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1474-8673.1982.tb00489.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T15:44:48Z","timestamp":1699631088000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1474-8673.1982.tb00489.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,9]]},"references-count":238,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1982,9]]}},"alternative-id":["10.1111\/j.1474-8673.1982.tb00489.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1474-8673.1982.tb00489.x","archive":["Portico"],"relation":{},"ISSN":["0144-1795","1365-2680"],"issn-type":[{"value":"0144-1795","type":"print"},{"value":"1365-2680","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,9]]}}}